General Dermatology

The new research identified notable improvements in disease severity, sweat reduction, and quality of life for patients treated with sofpironium.

Hawkes shared his excitement for the near future of dermatology, recognizing the increasing ability to provide tailored care to patients.

Jackson discusses EVO756, a promising MRGPRX2 antagonist targeting mast cells to treat chronic inflammatory diseases like spontaneous urticaria.

Take a look back at this year's newly FDA-approved dermatology devices and drugs.

In case you missed it, this week we had news about the 308 nm excimer light and 2940 erbium laser for vitiligo, the new Diamond technique for the neck and décolleté, potential risk factors for developing CHE in China, and more.

Fall Editor in Chief Raj Chovatiya, MD, PhD, MSCI, celebrates the joy of diverse traditions and reflects on the path to equity in dermatology as we move toward a brighter 2025.

A reflection on 2024's dermatology advancements, from FDA approvals to expert insights, setting the stage for another transformative year in 2025.

In case you missed it, this week we had news about the FDA-approval of Yesintek for psoriasis treatment, APG777 clinical trial updates, our inaugural Horizons in Advanced Practice meeting, and more.

Certain dermoscopic features in cutaneous warts may be associated with a favorable cryotherapy response.

The algorithm demonstrated 81% accuracy, promising fast, reliable, and reproducible assessments for patients. 

Investigating podiatry students' diagnostic accuracy and reasoning for dermatological lesions across skin tones using a mixed-method research approach.

Dermatology Times is looking back on the top stories in dermatology from the month of November.

Dermatology Times is recapping our top expert interviews from the month of November.

Hawkes highlighted the intersection of oncology and dermatology, focusing on immune checkpoint inhibitors and their cutaneous adverse events.

Learn more about the in-depth topics covered in the November 2024 print issue of Dermatology Times.

This study demonstrates the use of AI-driven image analysis, leveraging the ScarletredVision app and machine learning, to diagnose and assess onychomycosis.

Patients in 8 case studies saw notable improvements in post-traumatic, post-operative, and burn-related scars.

The study is set to begin enrollment later this year.

The ILDS has named 6 young dermatologists from around the world as recipients of the 2025 Young Dermatologists International Achievement Awards for their contributions to dermatology.

You're allowed to be proud of yourself, no matter how long you have been in practice, writes our Fall Editor in Chief Raj Chovatiya, MD, PhD.

At the 2024 SDPA Fall Conference, Audrey Rutherford, MD, discussed the critical role of vulvar biopsies in identifying cancer and other conditions to improve patient outcomes for underdiagnosed vulvar conditions.

Zirwas spoke with Dermatology Times to share the top clinical pearls and key takeaways from his discussion on contact dermatitis.

The target action date for the FDA decision is April 18, 2025.

November is Hyperhidrosis Awareness Month - test your knowledge on the subject.

The study calls for improved diversity in clinical training materials to help future clinicians better recognize conditions on darker skin.

Join Dermatology Times in celebrating National Healthy Skin Month.

November is Hyperhidrosis Awareness Month - test your knowledge on the subject.

With the Affordable Care Act's uncertain future, many Americans are curious about Robert F. Kennedy Jr.'s potential role in the new administration.

Murase noted small molecule treatments, like JAK inhibitors, remain unsafe for pregnant women.

In a session at Elevate-Derm West, Cheever presented on the utilization of AI within dermatology to optimize patient communication and diversify research.